Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Vitamin E intake and risk of amyotrophic lateral sclerosis.

Ascherio A, Weisskopf MG, O'reilly EJ, Jacobs EJ, McCullough ML, Calle EE, Cudkowicz M, Thun MJ.

Ann Neurol. 2005 Jan;57(1):104-10.

PMID:
15529299
2.

Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.

Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C.

Herz. 2003 Nov;28(7):628-38. Review.

PMID:
14689123
3.

Vitamin supplement use in a hospital-based population.

Barone J, Taioli E, Muscat J, Wynder EL.

Eur J Cancer Prev. 1992 Feb;1(2):139-48. Review.

PMID:
1463975
4.

Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases.

Majima HJ, Indo HP, Suenaga S, Matsui H, Yen HC, Ozawa T.

Curr Pharm Des. 2011;17(21):2190-5. Review.

PMID:
21774784
5.

[Risk factors in amyotrophic lateral sclerosis. Initial results apropos of 35 cases].

Grégoire N, Serratrice G.

Rev Neurol (Paris). 1991;147(11):706-13. Review. French.

PMID:
1775824
6.

2001 assessment of nutritional influences on risk for cataract.

Taylor A, Hobbs M.

Nutrition. 2001 Oct;17(10):845-57. Review.

PMID:
11684392
7.

Clinical inquiries. In patients with a previous CVA, do antioxidants protect against subsequent stroke?

Spencer DC, Meadows SE, Sontheimer D.

J Fam Pract. 2002 Nov;51(11):976. Review. No abstract available.

PMID:
12485555
8.

[Nutrition and health--unclear association between intake of vitamin E and the risk of coronary heart disease].

Buijsse B, Feskens EJ, Kromhout D.

Ned Tijdschr Geneeskd. 2003 Oct 11;147(41):2007-11. Review. Dutch.

PMID:
14587142
9.
10.

Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis.

Ngo ST, Steyn FJ, McCombe PA.

J Neurol Sci. 2014 May 15;340(1-2):5-12. doi: 10.1016/j.jns.2014.02.035. Epub 2014 Mar 3. Review.

11.

[Vitamin E as a natural antioxidant. Preventive importance and requirement].

Biesalski HK.

Med Monatsschr Pharm. 1993 Jul;16(7):197-203. Review. German. No abstract available.

PMID:
8366841
12.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638

Supplemental Content

Support Center